Skip to main content

Terazosin

NDC 69452-332 · Bionpharma Inc.

Generic nameTerazosin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)TERAZOSIN HYDROCHLORIDE
Strength5 mg/1
Pharmacologic classAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
Marketing categoryANDA

Packages

69452-332-20 — 100 CAPSULE in 1 BOTTLE (69452-332-20)

69452-332-32 — 1000 CAPSULE in 1 BOTTLE (69452-332-32)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68788-8171 — terazosin, 68788-9815 — Terazosin hydrochloride, 68788-9816 — Terazosin hydrochloride, 68788-9817 — Terazosin hydrochloride, 69292-201 — Terazosin Hydrochloride, 69292-202 — Terazosin Hydrochloride, 69292-203 — Terazosin Hydrochloride, 69292-204 — Terazosin Hydrochloride, 69452-330 — Terazosin, 69452-331 — Terazosin, 69452-333 — Terazosin, 70518-0074 — Terazosin Hydrochloride, 70518-0317 — Terazosin Hydrochloride, 70518-0342 — Terazosin Hydrochloride, 70518-3193 — terazosin, 70518-4545 — Terazosin, 70954-592 — Terazosin, 71335-3059 — Terazosin, 71335-3123 — Terazosin, 71335-3131 — Terazosin, +62 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.